Q: Just wanted to point out something with respect to your comment on NHC for Maria.
NHC does trade at 26x 2015 earnings estimates as you suggested, but this number gets cut in half for 2016 (i.e. ~13x P/E). Is it really fair to look at 2015E for a hyper growth company in October ? I don't believe investors would value a growth stock like NHC on 2015 figures...especially when they set to double their EBITDA and earnings for 2016.
When one compares 2016 estimates, NHC is actually cheaper than DR. DR has earnings dropping from 2015 where NHC is set to double.
Please correct me if I'm wrong, but I don't find your comparison of one being expensive vs. cheap accurate at all.
NHC does trade at 26x 2015 earnings estimates as you suggested, but this number gets cut in half for 2016 (i.e. ~13x P/E). Is it really fair to look at 2015E for a hyper growth company in October ? I don't believe investors would value a growth stock like NHC on 2015 figures...especially when they set to double their EBITDA and earnings for 2016.
When one compares 2016 estimates, NHC is actually cheaper than DR. DR has earnings dropping from 2015 where NHC is set to double.
Please correct me if I'm wrong, but I don't find your comparison of one being expensive vs. cheap accurate at all.